StockTipsArenaBeta

SELL Mankind Pharma Limited — Macquarie

SELLMankind Pharma Limited
Mankind Pharma share price target & all analyst calls

byMacquarieHorizon: NA (inferred 1 year)7 Oct 2026via Zee Business (Live)

Entry₹2,505.9Inferred
Target₹2,200
Total upside +12.21%
Stop lossNot given
CMP₹2,3803h ago
Active+5.02%+7.56%upside left 12 mo left
Follow Macquarie for new callsGet alertsWatch MANKIND for new buy/sell callsGet alertsSee 8 other Long-term calls on MANKINDSee 105 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.

As of 8 Oct, 7:53 pm IST
2 supporting12 neutral15 opposing
Supports the SELL call (2)

Mankind Pharma auditor resigns as subsidiary Bharat Serums enters liquidation

NewsGoogle News·28 Sept · 1w ago

(opens in new tab)

Mankind Pharma's subsidiary Bharat Serums and Vaccines sees auditor resignation amid liquidation

NewsGoogle News·28 Sept · 1w ago

(opens in new tab)
Neutral / worth noting (12)

Mankind Pharma To Give Rs 1 Crore To Flydubai Captain Smit Machchhar, Family For Averting Flight Disaster

NewsNdtv-Profit·3 Oct · 4d ago

(opens in new tab)

Mankind Pharma Gets 68.21 ESG Rating From Niche99 In Leader Category

NewsGoogle News·16 Sept · 3w ago

(opens in new tab)

Mankind Pharma to attend three investor conferences in September 2026

NewsGoogle News·11 Sept · 4w ago

(opens in new tab)

Mankind Pharma to meet investors in Mumbai on June 1-2

NewsGoogle News·11 Sept · 4w ago

(opens in new tab)
Weighs against the SELL call (15)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·7 Oct · yesterday

3 advisors have active short-term BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·30 Sept · 1w ago

Mankind Pharma shares up 10% in just 4 sessions; Kotak upgrades the stock - Target, share price trend

NewsLivemint·22 Sept · 2w ago

(opens in new tab)

Mankind Pharma shares get an upgrade from Kotak; Price target among top five on the street

NewsCnbc-Tv18·22 Sept · 2w ago

(opens in new tab)

6 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·22 Sept · 2w ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Mankind Pharma

All analyst calls on Mankind Pharma

More from Macquarie

Every call and its outcome